FDA launches effort aimed at preventing drug errors
NEWS IN BRIEF — Posted Nov. 16, 2009
The Food and Drug Administration in November announced an initiative aimed at preventing the annual 1.5 million adverse drug events that cost the American health system $4 billion a year. The agency's broad-ranging Safe Use Initiative will involve input from doctors, nurses, pharmacists and other government agencies on how to stop mistakes in prescribing, administration, and patient use.
The FDA already has launched programs aimed at mitigating the liver toxicity risks associated with acetaminophen overuse, fires related to topical alcohol-based surgical preps, and dosing mistakes attributed to some devices and vials. A 28-page report about the initiative is available at the FDA's Web site (link).
Note: This item originally appeared at http://www.ama-assn.org/amednews/2009/11/16/prbf1116.htm.